Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy

Background: Gonadotropin-releasing hormone agonists (GnRHa), used in the treatment of prostate cancer (PC) and for reproductive purposes in women, have been implicated as the cause of pituitary apoplexy (PA), a potentially life-threatening condition. The pathophysiology of PA after GnRHa has not bee...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Endocr Soc
Asıl Yazarlar: Yu, Xiaoling, Guarda, Francisco J, Shiraliyeva, Naila, Haines, Melanie S, Saylor, Philip J, Nachtigall, Lisa B
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2021
Konular:
Neuroendocrinology and Pituitary
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090722/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1281
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller